FDA panel to review adverse events for 12 drugs
This article was originally published in Scrip
Executive Summary
The US FDA's paediatric advisory committee will meet on June 23rd to review adverse event reports for 12 drugs pursuant to the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.